Literature DB >> 22102457

Prevalence and risk factors of muscle complications secondary to statins.

Khalid El-Salem1, Bashar Ababneh, Stacy Rudnicki, Ahmad Malkawi, Ali Alrefai, Yousef Khader, Ruba Saadeh, Mohammad Saydam.   

Abstract

INTRODUCTION: The aim of the study was to investigate the prevalence and risk factors of muscle complications among patients using statins.
METHODS: We conducted a prospective comparative study on 345 patients receiving statins and compared the findings with an age- and gender-matched control group of 85 subjects. Univariate and multivariate analyses with logistic regression models were used to study the association of different patient and disease characteristics with muscle complications.
RESULTS: Adverse reactions were reported by 21% of patients and 5.9% of controls (P = 0.0013). Objective weakness was found in 15% of the patients who reported muscle symptoms (3.2% of the total cohort), but not in controls. Older age, longer duration of statin use, diabetes, stroke, and lower body mass index were associated with increased risk of developing these symptoms.
CONCLUSIONS: Adverse reactions to statins may be more common than previously reported, and they may be affected by specific patient and disease characteristics.
Copyright © 2011 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22102457     DOI: 10.1002/mus.22205

Source DB:  PubMed          Journal:  Muscle Nerve        ISSN: 0148-639X            Impact factor:   3.217


  23 in total

Review 1.  Current drug treatment of hyperlipidemia in older adults.

Authors:  Dave L Dixon; Krista L Donohoe; Kelechi C Ogbonna; Sarah M Barden
Journal:  Drugs Aging       Date:  2015-02       Impact factor: 3.923

Review 2.  The effects of statin medications on aerobic exercise capacity and training adaptations.

Authors:  Zsolt Murlasits; Zsolt Radák
Journal:  Sports Med       Date:  2014-11       Impact factor: 11.136

3.  SLCO1B1 521T > C polymorphism associated with rosuvastatin-induced myotoxicity in Chinese coronary artery disease patients: a nested case-control study.

Authors:  Ju-E Liu; Xiao-Ying Liu; Sheng Chen; Yan Zhang; Li-Yun Cai; Min Yang; Wei-Hua Lai; Bin Ren; Shi-Long Zhong
Journal:  Eur J Clin Pharmacol       Date:  2017-08-15       Impact factor: 2.953

4.  Skeletal muscle ultrastructure and function in statin-tolerant individuals.

Authors:  Jason L Rengo; Damien M Callahan; Patrick D Savage; Philip A Ades; Michael J Toth
Journal:  Muscle Nerve       Date:  2015-12-09       Impact factor: 3.217

Review 5.  The impact of statins on physical activity and exercise capacity: an overview of the evidence, mechanisms, and recommendations.

Authors:  Allyson M Schweitzer; Molly A Gingrich; Thomas J Hawke; Irena A Rebalka
Journal:  Eur J Appl Physiol       Date:  2020-04-04       Impact factor: 3.078

Review 6.  Approach to Statin Use in 2016: an Update.

Authors:  P Elliott Miller; Seth S Martin
Journal:  Curr Atheroscler Rep       Date:  2016-05       Impact factor: 5.113

7.  Experimental development of bisphosphonate-related osteonecrosis of the jaws in rodents.

Authors:  Nicolau Conte Neto; Luis C Spolidorio; Cleverton R Andrade; Alliny S Bastos; Morgana Guimarães; Elcio Marcantonio
Journal:  Int J Exp Pathol       Date:  2013-02       Impact factor: 1.925

Review 8.  Toxic myopathies.

Authors:  Mamatha Pasnoor; Richard J Barohn; Mazen M Dimachkie
Journal:  Neurol Clin       Date:  2014-08       Impact factor: 3.806

9.  Development of AD-Like Pathology in Skeletal Muscle.

Authors:  X Chen; N M Miller; Z Afghah; J D Geiger
Journal:  J Parkinsons Dis Alzheimers Dis       Date:  2019-04-02

10.  The statin-iron nexus: anti-inflammatory intervention for arterial disease prevention.

Authors:  Leo R Zacharski; Ralph G DePalma; Galina Shamayeva; Bruce K Chow
Journal:  Am J Public Health       Date:  2013-02-14       Impact factor: 9.308

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.